SPI Stock Overview
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics.
No risks detected for SPI from our risk checks.
Spire Healthcare Group Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||UK£2.44|
|52 Week High||UK£2.57|
|52 Week Low||UK£2.01|
|1 Month Change||2.95%|
|3 Month Change||17.59%|
|1 Year Change||9.66%|
|3 Year Change||146.71%|
|5 Year Change||-27.36%|
|Change since IPO||15.91%|
Recent News & Updates
|SPI||GB Healthcare||GB Market|
Return vs Industry: SPI exceeded the UK Healthcare industry which returned 5.6% over the past year.
Return vs Market: SPI exceeded the UK Market which returned -6.8% over the past year.
|SPI Average Weekly Movement||3.7%|
|Healthcare Industry Average Movement||4.9%|
|Market Average Movement||5.4%|
|10% most volatile stocks in GB Market||10.8%|
|10% least volatile stocks in GB Market||2.7%|
Stable Share Price: SPI is less volatile than 75% of UK stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: SPI's weekly volatility (4%) has been stable over the past year.
About the Company
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. The company also provides eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, haematology, hand surgery, hip and knee treatment, and heart and kidney treatments.
Spire Healthcare Group Fundamentals Summary
|SPI fundamental statistics|
Is SPI overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|SPI income statement (TTM)|
|Cost of Revenue||UK£615.00m|
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
Sep 08, 2022
|Earnings per share (EPS)||-0.024|
|Net Profit Margin||-0.88%|
How did SPI perform over the long term?See historical performance and comparison
Is SPI undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 5/6
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for SPI?
Other financial metrics that can be useful for relative valuation.
|What is SPI's n/a Ratio?|
Price to Sales Ratio vs Peers
How does SPI's PS Ratio compare to its peers?
|SPI PS Ratio vs Peers|
|Company||PS||Estimated Growth||Market Cap|
CTH CareTech Holdings
CVSG CVS Group
MDC Mediclinic International
MDMG MD Medical Group Investments
SPI Spire Healthcare Group
Price-To-Sales vs Peers: SPI is good value based on its Price-To-Sales Ratio (0.9x) compared to the peer average (1.4x).
Price to Earnings Ratio vs Industry
How does SPI's PE Ratio compare vs other companies in the European Healthcare Industry?
Price-To-Sales vs Industry: SPI is good value based on its Price-To-Sales Ratio (0.9x) compared to the UK Healthcare industry average (1.7x)
Price to Sales Ratio vs Fair Ratio
What is SPI's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PS Ratio||0.9x|
|Fair PS Ratio||2.7x|
Price-To-Sales vs Fair Ratio: SPI is good value based on its Price-To-Sales Ratio (0.9x) compared to the estimated Fair Price-To-Sales Ratio (2.7x).
Share Price vs Fair Value
What is the Fair Price of SPI when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: SPI (£2.44) is trading below our estimate of fair value (£5.56)
Significantly Below Fair Value: SPI is trading below fair value by more than 20%.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
How is Spire Healthcare Group forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?
Future Growth Score4/6
Future Growth Score 4/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SPI is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.9%).
Earnings vs Market: SPI is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: SPI is expected to become profitable in the next 3 years.
Revenue vs Market: SPI's revenue (4.4% per year) is forecast to grow faster than the UK market (4.1% per year).
High Growth Revenue: SPI's revenue (4.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: SPI's Return on Equity is forecast to be low in 3 years time (7.1%).
Discover growth companies
How has Spire Healthcare Group performed over the past 5 years?
Past Performance Score0/6
Past Performance Score 0/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: SPI is currently unprofitable.
Growing Profit Margin: SPI is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: SPI is unprofitable, and losses have increased over the past 5 years at a rate of 60.1% per year.
Accelerating Growth: Unable to compare SPI's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: SPI is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (122.9%).
Return on Equity
High ROE: SPI has a negative Return on Equity (-1.26%), as it is currently unprofitable.
Discover strong past performing companies
How is Spire Healthcare Group's financial position?
Financial Health Score4/6
Financial Health Score 4/6
Short Term Liabilities
Long Term Liabilities
Stable Cash Runway
Forecast Cash Runway
Financial Position Analysis
Short Term Liabilities: SPI's short term assets (£346.8M) exceed its short term liabilities (£302.1M).
Long Term Liabilities: SPI's short term assets (£346.8M) do not cover its long term liabilities (£1.2B).
Debt to Equity History and Analysis
Debt Level: SPI's net debt to equity ratio (32%) is considered satisfactory.
Reducing Debt: SPI's debt to equity ratio has increased from 41% to 60.8% over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable SPI has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: SPI is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 26.6% per year.
Discover healthy companies
What is Spire Healthcare Group current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Cash Flow Coverage
Forecast Dividend Yield
Dividend Yield vs Market
Notable Dividend: Unable to evaluate SPI's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate SPI's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if SPI's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if SPI's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: SPI is not paying a notable dividend for the UK market.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as SPI has not reported any payouts.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Mr. Justin J. Ash, BA (Hons), has been the Chief Executive Officer and Executive Director of Spire Healthcare Group Plc since October 30, 2017. Mr. Ash served as the Chief Executive Officer at Oasis Health...
CEO Compensation Analysis
Compensation vs Market: Justin's total compensation ($USD2.54M) is above average for companies of similar size in the UK market ($USD1.35M).
Compensation vs Earnings: Justin's compensation has increased whilst the company is unprofitable.
Experienced Management: SPI's management team is considered experienced (3.6 years average tenure).
Experienced Board: SPI's board of directors are considered experienced (4.3 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: SPI insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Spire Healthcare Group plc's employee growth, exchange listings and data sources
- Name: Spire Healthcare Group plc
- Ticker: SPI
- Exchange: LSE
- Founded: 2007
- Industry: Health Care Facilities
- Sector: Healthcare
- Implied Market Cap: UK£984.859m
- Shares outstanding: 403.63m
- Website: https://www.spirehealthcare.com
Number of Employees
- Spire Healthcare Group plc
- 3 Dorset Rise
- Greater London
- EC4Y 8EN
- United Kingdom
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/08/08 00:00|
|End of Day Share Price||2022/08/08 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.